| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/27/1992 | CA2074484A1 Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same |
| 05/27/1992 | CA2055992A1 Method of increasing the muscle/fat ratio in agricultural domestic animals |
| 05/27/1992 | CA2054638A1 Benzodiazolo analogs |
| 05/26/1992 | US5117042 15-keto-prostaglandin compound for improvement of encephalic function |
| 05/26/1992 | US5117022 Antitumor |
| 05/26/1992 | US5116992 Antitumor |
| 05/26/1992 | US5116986 Heteroaromatic amine derivatives |
| 05/26/1992 | US5116984 5-hydroxytryptamine antagonists |
| 05/26/1992 | US5116979 Dihydrocaffeic acid derivatives and pharmaceutical preparations containing same |
| 05/26/1992 | US5116974 3-carbalkoxyamino-5-aminoacyl-5H-dibenz[b,f]azepines, and methods for making |
| 05/26/1992 | US5116971 Platelt-activating-factor antagonist |
| 05/26/1992 | US5116968 Macrolide compounds |
| 05/26/1992 | US5116963 Anticoagulants |
| 05/26/1992 | US5116960 Amphotericin b derivatives |
| 05/26/1992 | US5116949 Benzoyl urea compound-albumin complex |
| 05/26/1992 | US5116878 Medicinal composition for the treatment and prevention of the symptoms of heart failure, containing a vasoconstrictor alpha-stimulant agent as active principle |
| 05/26/1992 | US5116877 Muscle Relaxants |
| 05/26/1992 | US5116873 Thyroid Hormone T4 |
| 05/26/1992 | US5116871 Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis |
| 05/26/1992 | US5116867 Not adrenergic blocking agent; respiratory system disorders |
| 05/26/1992 | US5116865 15,16-seco-19-nor progestins |
| 05/26/1992 | US5116864 Method for preventing restenosis following reconfiguration of body vessels |
| 05/26/1992 | US5116863 Dibenz[b,e]oxepin derivative and pharmaceutical compositions thereof |
| 05/26/1992 | US5116859 Administering N- -2-(diethylamino)-ethyl!-2-methoxy-4- (1-H-4,5-dihydro-2-imidazolyl) -amino!-5-chlorobenzamide or salt |
| 05/26/1992 | US5116858 Learning enhancement |
| 05/26/1992 | US5116857 Method of increasing gastrointestinal motility with substituted benzamides |
| 05/26/1992 | US5116856 Aminoethylthiazole and aminoethyloxazole derivatives |
| 05/26/1992 | US5116853 Phenylene derivatives |
| 05/26/1992 | US5116852 Treatment of sleep disorders |
| 05/26/1992 | US5116851 Pharmaceutical composition and method for treating cardiovascular diseases using substituted anilides and sulfonamides |
| 05/26/1992 | US5116849 4-amidino chroman and 4-amidino pyrano (3,2-c) pyridine derivatives, a process for their preparation and pharmaceutical compositions containing them |
| 05/26/1992 | US5116848 N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents |
| 05/26/1992 | US5116847 Use of loperamide and related compounds for treatment of respiratory disease symptoms |
| 05/26/1992 | US5116846 N-aralkyl piperidine derivatives as psychotropic drugs |
| 05/26/1992 | US5116845 BU-3420T antitumor antibiotic |
| 05/26/1992 | US5116844 Triazole antifungal agents |
| 05/26/1992 | US5116843 Anticoagulants, hypotensive agents and cardiovascular disorder |
| 05/26/1992 | US5116842 Chemical compounds |
| 05/26/1992 | US5116841 Psychopharmaceuticals |
| 05/26/1992 | US5116839 Treatment of senility |
| 05/26/1992 | US5116837 2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines |
| 05/26/1992 | US5116833 Antibiotic c-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof |
| 05/26/1992 | US5116832 Penem derivatives production and use thereof |
| 05/26/1992 | US5116828 Pharmaceutical composition for treatment of osteoporosis |
| 05/26/1992 | US5116823 Drug combinations containing AZT |
| 05/26/1992 | US5116821 Sulfated glyceroglucolipids as inhibitors of bacterial adherence |
| 05/26/1992 | US5116820 Intestinal absorption inhibiting agent |
| 05/26/1992 | US5116815 Pf 1022 substance, method of treating helminthic parasitic infection and anthelmintic composition |
| 05/26/1992 | US5116624 Efa compositions and therapy |
| 05/26/1992 | US5116621 Anti-inflammatory analgesic patch |
| 05/26/1992 | US5116619 Vaginal progesterone tablet |
| 05/26/1992 | US5116617 Pharmaceutical composition for topical use in the treatment of the capillary fragility |
| 05/26/1992 | US5116610 Cholestyramine Resin |
| 05/26/1992 | US5116603 Oral antifungal preventative, and method of use |
| 05/26/1992 | US5116600 Oxonic acid |
| 05/26/1992 | US5116573 Labelled vitamin d3 derivative and production process thereof |
| 05/26/1992 | CA1302005C Aminoacid derivatives as antihypertensives |
| 05/26/1992 | CA1301776C Compound of choline, a process for its preparation and therapeutic composition containing it |
| 05/26/1992 | CA1301770C Isothiuronium salts |
| 05/26/1992 | CA1301762C Dichloroaniline derivatives |
| 05/26/1992 | CA1301760C Pyridonecarboxylic acid derivatives having 3-[amino(alkyl)methyl]-pyrrolidine |
| 05/26/1992 | CA1301759C Pyranopyridines having antihypertensive activity |
| 05/26/1992 | CA1301757C Substituted 1-¬aralkyl- piperazinoalkyl|cycloalkanols |
| 05/26/1992 | CA1301756C Anti-tumour agents |
| 05/26/1992 | CA1301753C Process for preparing histamine h_-antagonist and intermediates used in such process |
| 05/26/1992 | CA1301750C 13-deoxy-23-oxo(keto) and 23-imino derivatives of 13-deoxy c-076-aglycone compounds |
| 05/26/1992 | CA1301749C Macrolide compounds |
| 05/26/1992 | CA1301746C C(29)-oximinomilbemycin derivatives, process for their preparation and use as insecticides and parasiticides |
| 05/26/1992 | CA1301745C Macrolide antibiotics and their preparation |
| 05/26/1992 | CA1301655C2 Pharmaceutical compositions containing 2,4-dimethyl-5-phenyl-3h-1,2,4-triazole-3-thione |
| 05/26/1992 | CA1301654C Composition for the topical treatment of glaucoma or ocular hypertension |
| 05/26/1992 | CA1301653C Skin treatment composition |
| 05/26/1992 | CA1301652C Continuous intravenous infusion of adenosine to human patients |
| 05/26/1992 | CA1301651C Pharmaceutical composition containing pregnanolone |
| 05/26/1992 | CA1301649C Treatment of cancer with phlorizin and its derivatives |
| 05/25/1992 | WO1992009281A2 Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia |
| 05/25/1992 | CA2096853A1 Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia |
| 05/25/1992 | CA2056063A1 Aminodiol derivatives |
| 05/25/1992 | CA2056009A1 Heterocyclically substituted piperazinoalkylbenzoxazine and piperazinolkylbenzothiazine compounds, processes for preparing them, and medicaments containing them |
| 05/24/1992 | WO1992009602A1 Pyridobenzoindole derivatives, their preparation method, and pharmaceutical compositions containing same |
| 05/24/1992 | WO1992009573A2 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 05/24/1992 | CA2096848A1 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 05/24/1992 | CA2096719A1 Pyridobenzoindole derivatives, their preparation and pharmaceutical compositions containing them |
| 05/24/1992 | CA2056008A1 Benzoselenazolinone derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 05/23/1992 | WO1992009571A1 Medicaments containing sulphonamides, novel sulphonamides and proces for producing them |
| 05/23/1992 | CA2096847A1 Pharmaceutical preparations containing sulfonamides novel sulfonamides and processes for their production |
| 05/23/1992 | CA2055950A1 Pyridyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 05/23/1992 | CA2055946A1 Chemical process |
| 05/22/1992 | WO1992009556A1 Improved matrix metalloprotease inhibitors |
| 05/22/1992 | WO1992009203A1 Tnf inhibitors |
| 05/22/1992 | CA2096623A1 Tnf inhibitors |
| 05/22/1992 | CA2096221A1 Matrix metalloprotease inhibitors |
| 05/21/1992 | WO1992008729A1 Antisense nucleic acid derivative |
| 05/21/1992 | DE4036571A1 Verwendung von 2h-1,2,4-benzothiadiazin-3(4h)-thion-1,1- dioxiden als antivirale arzneimittel Use of 2H-1,2,4-benzothiadiazine-3 (4H) -thione-1,1-dioxides as antiviral drugs |
| 05/21/1992 | CA2096658A1 Anti-sense nucleic acid derivative |
| 05/21/1992 | CA2055859A1 Oxazolopyridine derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 05/21/1992 | CA2055844A1 Slow-releasing composition of platinum-containing anticancer agent |
| 05/20/1992 | WO1992008985A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/20/1992 | EP0486477A2 1-( -D-Arabinofuranosyl)-5-propynyluracil as a VZV-antiviral compound |
| 05/20/1992 | EP0486395A1 Aqueous gel based on retinoic acid and hydroxypropyl-beta-cycclodextrin |